CN Bio Innovations (CN Bio) announced today the appointment of Gavin Clark to the role of Director of Licensing. This is a new position created to facilitate the commercialization of CN Bio’s novel proprietary infectious disease models.
Gavin brings with him over 35 years of experience in the pharmaceutical industry including roles as Global Licensing Manager for Anti-Infectives at Glaxo and VP Business Development at Tibotec-Virco NV.
David Scales, Chief Executive of CN Bio says “I am delighted to welcome Gavin on behalf of the CN Bio team. His wealth of licensing and deal making expertise, particularly in the infectious diseases area, will be a great asset to our commercial team. “
“CN Bio is rare in having the potential to radically alter the speed and success of new drug regimens for our partners and millions of affected patients” said Gavin Clark. “I am excited to join CN Bio at the launch of our first-in-field technologies to the challenging antiviral therapeutic area”.
Gavin joins CN Bio as a key member of the new Partner Engagement Team with immediate effect.filed under: Business